Search results
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Motley Fool via Yahoo Finance· 2 months agoSince 2021, shares of Novavax (NASDAQ: NVAX) have absolutely crumbled, falling by a whopping 95%....
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 2 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
Why Investors Yawned at Novavax's Great FDA Panel News
Motley Fool· 2 years agoTuesday was a crucial day for Novavax (NASDAQ: NVAX). At long last, the U.S. Food and Drug...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Investor's Business Daily· 2 years agoNovavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Novavax's COVID-19 vaccine rollout off to sluggish start with just 7,000 doses in arms
ABC News via Yahoo News· 2 years agoFollowing its emergency authorization last month, just 7,300 doses of Novavax's COVID-19 vaccine...
Novavax Stock Soars 25%. A Vaccine Purchase Settlement Is One Reason Why.
Barrons.com· 2 months agoNovavax was rising sharply Thursday after the vaccine maker reached a settlement with...
Why Novavax Stock Tumbled 28% in the First Half of 2023
Motley Fool· 10 months agoWhat happened Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of...